D-0114-2018 Class I Terminated
FDA drug recall D-0114-2018 was initiated by Advanced Pharma Inc. on Jun 9, 2017 and is designated Class I. Reason for recall: Subpotent Drug: found to be below the specification for labeled assay. The recall status is terminated (terminated Apr 3, 2019). Affected quantity: 320 syringes.
Recall details
- Product Type
- Drugs
- Report Date
- Dec 27, 2017
- Initiation Date
- Jun 9, 2017
- Termination Date
- Apr 3, 2019
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 320 syringes
Product description
NitroGlycerin (1 mg/5 mL) 1 mg in 5% Dextrose Inj, USP QS 5 mL (200 mcg per mL), 5 mL Sterile single dose syringe, packaged in 8 x 5 (FORTY) syringes per box, Rx only, Advanced Pharma, 9265 Kirby Dr., Houston, TX 77054, NDC 15082-863-67.
Reason for recall
Subpotent Drug: found to be below the specification for labeled assay.
Distribution pattern
Nationwide in the USA to hospitals and medical facilities.
Code information
Lot: 4/10/17 1441 257-86367S, BUD 6/9/17; 4/17/17 0950 86367S, BUD¿6/16/2017; 4/20/17 1505 257-86367S, BUD 6/19/2017; 4/24/17 0115 15-86367S, BUD ¿6/23/2017; 4/26/17 0301 387-86367S, BUD 6/25/2017
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0114-2018
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026